However, Tavazoie Masoud F's study showed that liver-X nuclear receptor (LXR) /ApoE activation therapy elicited robust anti-tumor responses and enhanced T cell activation during various immune-based therapies 15. This evidence concerns the gene APOE and neoplasm.